ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 246,04
0,57%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Quince Therapeutics Inc (QNCX)

  7. Quince Therapeutics Inc (QNCX) Actualités

QNCX Quince Therapeutics Inc

0,9851
0,0251 (2,61%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Quince Therapeutics Inc QNCX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0251 2,61% 0,9851 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,92 0,92 0,99 0,9851 0,96
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/4/202413:00BWQuince Therapeutics Provides Business Update and Reports..
22/2/202413:00BWQuince Therapeutics Launches Scientific Advisory Board
15/2/202422:00EDGAR2Form 8-K - Current report
15/2/202413:00BWQuince Therapeutics Appoints Former Reata Pharmaceuticals..
07/2/202422:05BWQuince Therapeutics to Present at Oppenheimer 34th Annual..
02/2/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:01EDGAR2Form 8-K/A - Current report: [Amend]
04/1/202422:05BWQuince Therapeutics to Participate at Investor Events in..
03/1/202422:02EDGAR2Form 8-K - Current report
22/12/202322:08EDGAR2Form 8-K - Current report
15/12/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:06EDGAR2Form 8-K - Current report
08/12/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202319:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202323:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202301:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/10/202322:05EDGAR2Form 8-K - Current report
23/10/202313:00BWQuince Therapeutics Completes Acquisition of EryDel S.p.A.
28/9/202322:53DJNQuince Therapeutics to Advance Study of EryDex as FDA Lifts..
28/9/202322:05BWU.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s..
06/9/202313:18EDGAR2Form 8-K - Current report
06/9/202313:00BWQuince Therapeutics Appoints Dr. Charles S. Ryan as..
01/9/202300:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202323:05EDGAR2Form 8-K - Current report
10/8/202322:05BWQuince Therapeutics to Present at Sidoti Virtual Investor..
10/8/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202300:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/7/202323:56BWQuince Therapeutics rileva EryDel SpA e il suo asset di fase..
24/7/202313:16EDGAR2Form 8-K - Current report
24/7/202313:00BWQuince Therapeutics to Acquire EryDel SpA and its Phase 3..

Dernières Valeurs Consultées

NASDAQ
QNCX
Quince Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés